Reason for request
Inclusion on the list of products reimbursed by National Insurance and for hospital use in the extension of indication: "Symptomatic relief in the treatment of ankylosing spondylitis".
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités est important dans l'extension d’indication : soulagement des symptômes dans le traitement de la spondylarthrite ankylosante.
|
Clinical Added Value
| no clinical added value |
Dans le traitement de la spondylarthrite ankylosante, CELEBREX® n'apporte pas d'amélioration du service médical rendu (V) par rapport aux autres AINS.
|
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
pSaGM3k3Hfkb0kJc
